selegiline has been researched along with mofegiline in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (11.11) | 18.7374 |
| 1990's | 8 (88.89) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Heikkila, RE; Terleckyj, IA | 1 |
| DeLanney, LE; Finnegan, KT; Irwin, I; Langston, JW; Skratt, JJ | 1 |
| Dudley, MW | 1 |
| Boismenu, D; Mamer, O; Montgomery, J; Ste-Marie, L; Vachon, L | 1 |
| Huber, EW; Ohlweiler, DF; Thomas, CE | 1 |
| Lamarre-Théroux, L; Poirier, J; Quirion, R; Thiffault, C | 1 |
| Poirier, J; Quirion, R; Thiffault, C | 1 |
| Deng, Y; Yu, PH | 1 |
| Bémeur, C; Lambert, J; Montgomery, J; Ste-Marie, L; Vachon, L | 1 |
9 other study(ies) available for selegiline and mofegiline
| Article | Year |
|---|---|
In vivo and in vitro pharmacologic profile of two new irreversible MAO-B inhibitors: MDL 72,974A and fluorodeprenyl.
Topics: Allyl Compounds; Animals; Brain; Butylamines; Isoenzymes; Mice; Monoamine Oxidase Inhibitors; Rats; Selegiline | 1992 |
Protection against DSP-4-induced neurotoxicity by deprenyl is not related to its inhibition of MAO B.
Topics: Allyl Compounds; Animals; Benzylamines; Butylamines; Hippocampus; Kinetics; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Nervous System Diseases; Norepinephrine; Selegiline | 1990 |
The depletion of rat cortical norepinephrine and the inhibition of [3H]norepinephrine uptake by xylamine does not require monoamine oxidase activity.
Topics: Allyl Compounds; Animals; Butylamines; Cerebral Cortex; Clorgyline; Desipramine; Kinetics; Male; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Nitrogen Mustard Compounds; Norepinephrine; Rats; Rats, Inbred Strains; Selegiline; Synaptosomes; Tyrosine | 1988 |
In vivo hydroxylation of the neurotoxin, 1-methyl-4-phenylpyridinium, and the effect of monoamine oxidase inhibitors: electrospray-MS analysis of intra-striatal microdialysates.
Topics: 1-Methyl-4-phenylpyridinium; Allyl Compounds; Animals; Butylamines; Dopamine Agents; Hydroxyl Radical; Hydroxylation; Male; Mass Spectrometry; Microdialysis; Monoamine Oxidase Inhibitors; Neostriatum; Rats; Rats, Sprague-Dawley; Selegiline; Spectrometry, Mass, Fast Atom Bombardment | 1996 |
Hydroxyl and peroxyl radical trapping by the monoamine oxidase-B inhibitors deprenyl and MDL 72,974A: implications for protection of biological substrates.
Topics: Allyl Compounds; Antiparkinson Agents; Butylamines; Deoxyribose; Hydroxyl Radical; In Vitro Techniques; Lipid Peroxidation; Liposomes; Monoamine Oxidase Inhibitors; Oxidation-Reduction; Oxidative Stress; Peroxides; Selegiline; Thiobarbituric Acid Reactive Substances | 1997 |
L-Deprenyl and MDL72974 do not improve the recovery of dopaminergic cells following systemic administration of MPTP in mouse.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Allyl Compounds; Animals; Butylamines; Cell Count; Corpus Striatum; Dopamine; Dopamine Agents; Drug Evaluation, Preclinical; Injections, Intraperitoneal; Male; Mice; Mice, Inbred C57BL; Monoamine Oxidase Inhibitors; Neurons; Neuroprotective Agents; Selegiline | 1997 |
The effect of L-deprenyl, D-deprenyl and MDL72974 on mitochondrial respiration: a possible mechanism leading to an adaptive increase in superoxide dismutase activity.
Topics: Allyl Compounds; Animals; Antiparkinson Agents; Brain; Butylamines; Cattle; Cerebellum; Corpus Striatum; Dopamine; Erythrocytes; Kinetics; Mice; Mice, Inbred C57BL; Mice, Inbred Strains; Mitochondria; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Norepinephrine; Oxidative Stress; Oxygen Consumption; Rats; Selegiline; Stereoisomerism; Superoxide Dismutase | 1997 |
Assessment of the deamination of aminoacetone, an endogenous substrate for semicarbazide-sensitive amine oxidase.
Topics: Acetone; Allyl Compounds; Amine Oxidase (Copper-Containing); Benzylamines; Butylamines; Catalysis; Chromatography, High Pressure Liquid; Clorgyline; Deamination; Enzyme Inhibitors; Humans; Kinetics; Monoamine Oxidase Inhibitors; Phenylenediamines; Pyruvaldehyde; Selegiline; Semicarbazides; Umbilical Arteries | 1999 |
Local striatal infusion of MPP+ does not result in increased hydroxylation after systemic administration of 4-hydroxybenzoate.
Topics: 1-Methyl-4-phenylpyridinium; Allyl Compounds; Animals; Antioxidants; Butylamines; Corpus Striatum; Dopamine; Free Radical Scavengers; Hydroxybenzoates; Hydroxyl Radical; Hydroxylation; Injections, Intraperitoneal; Male; Microdialysis; Monoamine Oxidase Inhibitors; Neurotoxins; Parabens; Parkinson Disease; Rats; Rats, Sprague-Dawley; Selegiline | 1999 |